Trials / Completed
CompletedNCT02889341
Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Vida Recoletas Sevilla · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Sperm parameters will be examined before DHA (DHA=Docosahexanoic Acid) consumption, after one months and after 2 months taken Docosahexanoic Acid or placebo.
Detailed description
Prospective, randomized, double blind, placebo-controlled intervention study within individuals. Assisted reproduction unit and academic research laboratory. One hundred an eighty human semen samples from 60 infertile patients of IVI Sevilla clinic were finally included. Assessment of oxidative stress, apoptosis, lipid peroxidation, mitochondrial membrane potential, DNA fragmentation and standard sperm parameters before and after supplementation with different DHA doses (0.5, 1 and 2 g) or placebo for 1 and 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | DHA | |
| OTHER | Placebo |
Timeline
- Start date
- 2013-10-22
- Primary completion
- 2015-05-26
- Completion
- 2017-03-01
- First posted
- 2016-09-05
- Last updated
- 2017-08-02
Source: ClinicalTrials.gov record NCT02889341. Inclusion in this directory is not an endorsement.